a 75925 has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albuquerque, MG; Ceva Antunes, OA; da Cunha, EF; de Alencastro, RB; de Castro Ramalho, T; Sippl, W | 1 |
| Aimi, N; Baba, M; Fujiwara, M; Hanasaki, Y; Ide, T; Ijichi, K; Katsuura, K; Konno, K; Shigeta, S; Takayama, H; Yokota, T | 1 |
2 other study(ies) available for a 75925 and HIV Coinfection
| Article | Year |
|---|---|
3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
Topics: Crystallography, X-Ray; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Models, Molecular; Molecular Conformation; Protein Binding; Quantitative Structure-Activity Relationship; Valine | 2009 |
Thiadiazole derivatives: highly potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replications in vitro.
Topics: Anti-HIV Agents; Cells, Cultured; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Leukocytes, Mononuclear; Oligopeptides; Protein Binding; Reverse Transcriptase Inhibitors; Thiadiazoles; Zidovudine | 1997 |